Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

Embryonic Stem Cells

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The kidney distal tubule potassium switch, modern diet and hypertension.

Nature reviews. Nephrology·2026

Same author

Crossing the finish line towards a disease-modifying treatment for Angelman syndrome.

Journal of neurodevelopmental disorders·2026

Same author

Non-hydrolyzable acetyllysine analogs to study protein acetylation in vitro and in cells.

Nature communications·2026

Same author

Case Report: Functional investigation of the γENaC G532S mutation presenting as mild PHA-1B3.

Frontiers in medicine·2025

Same author

Dietary K<sup>+</sup> supplementation restores normal aldosterone level in Na<sup>+</sup>-deprived renal tubule-specific CAP1/Prss8-deficient mice.

American journal of physiology. Renal physiology·2025

Same author

Combination of genetic studies and animal modeling proposes TMPRSS9 as a candidate gene for serum K<sup>+</sup> variations.

Scientific reports·2025

Search research articles

Related Experiment Video

Updated: Jul 9, 2026

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

HECT E3s and human disease.

Martin Scheffner¹, Olivier Staub

¹Department of Biology, University of Konstanz, 78457 Konstanz, Germany. martin.scheffner@uni-konstanz.de

BMC Biochemistry

|December 6, 2007

Summary

HECT E3 ligases, crucial for protein ubiquitination, are implicated in various human diseases. Targeting these enzymes offers potential therapeutic strategies for cancer and neurological disorders.

Area of Science:

Biochemistry
Molecular Biology
Genetics

Background:

HECT E3 ligases possess a modular structure with a catalytic HECT domain and variable N-terminal extensions.
These enzymes are critical for ubiquitin attachment to substrate proteins, determining substrate specificity.

Purpose of the Study:

To review the role of HECT E3 ligases in human diseases.
To highlight the therapeutic potential of targeting HECT E3 ligases and their substrates.

Main Methods:

Literature review of HECT E3 ligase function and disease association.
Analysis of the structural and functional properties of HECT E3 ligases.

Main Results:

HECT E3 ligases are involved in diverse diseases, including cancer, Liddle's syndrome, and Angelman syndrome.

More Related Videos

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Cultivation of Heligmosomoides Polygyrus: An Immunomodulatory Nematode Parasite and its Secreted Products

Cultivation of Heligmosomoides Polygyrus: An Immunomodulatory Nematode Parasite and its Secreted Products

Published on: April 6, 2015

Related Experiment Videos

Last Updated: Jul 9, 2026

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Cultivation of Heligmosomoides Polygyrus: An Immunomodulatory Nematode Parasite and its Secreted Products

Cultivation of Heligmosomoides Polygyrus: An Immunomodulatory Nematode Parasite and its Secreted Products

Published on: April 6, 2015

These enzymes also play roles in bone homeostasis, immune response, and retroviral budding.

Conclusions:

Targeting HECT E3 ligases, their regulators, or substrates presents a promising avenue for treating various human diseases.
Further research into HECT E3 ligase mechanisms could yield novel therapeutic interventions.